| Title | Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET. |
| Publication Type | Journal Article |
| Year of Publication | 2015 |
| Authors | Gordon, Stuart C., Andrew J. Muir, Joseph K. Lim, Brian Pearlman, Curtis K. Argo, Ananthakrishnan Ramani, Benedict Maliakkal, Imtiaz Alam, Thomas G. Stewart, Monika Vainorius, Joy Peter, David R. Nelson, Michael W. Fried, and Rajender K. Reddy |
| Corporate Authors | HCV-TARGET study group |
| Journal | Journal of hepatology |
| Volume | 62 |
| Issue | 2 |
| Pagination | 286-93 |
| Date Published | 2015 Feb |
| ISSN | 1600-0641 |
| Keywords | Adolescent, Adult, Aged, Antiviral Agents, DNA, Viral, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Follow-Up Studies, Genotype, Hepacivirus, Hepatitis C, Chronic, Humans, Male, Middle Aged, Oligopeptides, Proline, Retrospective Studies, Treatment Outcome, Viral Load, Young Adult |
| Abstract | The safety profiles of boceprevir and telaprevir in the treatment of chronic hepatitis C, administered in academic and community centres across the United States, were evaluated. |
| DOI | 10.1016/j.jhep.2014.08.052 |
| Alternate Journal | J. Hepatol. |
